Pinnacle Holdings LLC purchased a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 11,571 shares of the company’s stock, valued at approximately $1,487,000.
Several other institutional investors have also made changes to their positions in the stock. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in Merck KGaA during the second quarter valued at approximately $942,087,000. True Freedom Investing LLC purchased a new stake in Merck KGaA in the 2nd quarter worth approximately $6,818,000. Haverford Trust Co acquired a new stake in shares of Merck KGaA during the 2nd quarter valued at $35,005,000. Clear Harbor Asset Management LLC acquired a new stake in shares of Merck KGaA during the 2nd quarter valued at $5,511,000. Finally, Davis Asset Management L.P. purchased a new position in shares of Merck KGaA during the 2nd quarter valued at $514,000. 0.10% of the stock is currently owned by institutional investors and hedge funds.
Merck KGaA Stock Performance
OTCMKTS MKGAF opened at $163.21 on Monday. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56. The firm’s fifty day simple moving average is $162.62 and its 200-day simple moving average is $148.44. The company has a market capitalization of $21.09 billion, a PE ratio of 24.92 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
